A multicenter, randomized, open label study to compare the development of liver fibrosis at 12 months after transplantation for hepatitis C cirrhosis in patients receiving either Neoral or tacrolimus.

Trial Profile

A multicenter, randomized, open label study to compare the development of liver fibrosis at 12 months after transplantation for hepatitis C cirrhosis in patients receiving either Neoral or tacrolimus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2015

At a glance

  • Drugs Ciclosporin (Primary) ; Ciclosporin (Primary) ; Ciclosporin (Primary) ; Corticosteroids; Interleukin 2 receptor antagonists; Mycophenolic acid; Tacrolimus; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms REFINE
  • Sponsors Novartis Pharma A.G.
  • Most Recent Events

    • 10 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top